» Articles » PMID: 30016936

Metabolic Syndrome Among Type 2 Diabetic Patients in Ethiopia: a Cross-sectional Study

Overview
Publisher Biomed Central
Date 2018 Jul 19
PMID 30016936
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolic syndrome (MetS) increases risk of cardiovascular diseases (CVD), premature death as well as cost related to health care.This study was aimed at investigating the prevalence of MetS and its determinant factors among type2 diabetes mellitus (T2DM) patients attending a specialized hospital.

Methods: A cross-sectional study was conducted on a total of 256 T2DM patients from the first march to 30th May 2017 at university of gondar comprehensive specialized hospital (UGCSH). Data was collected based on STROBE (strengthening the reporting of observational studies in epidemiology) statement. Bivariable and multivariable logistic regression analysis were run to identify predictors of MetS from the independent variables and significance test was set at P <  0.05.

Results: The prevalence of MetS in this study was 70.3, 57 & 45.3% and it is more common in females (66.1, 83.3 & 70.7%) by using national cholesterol education program adult treatment panel III (NCEP-ATP III), International diabetic federation (IDF) and world health organization (WHO) criteria respectively. The most prevalent components of MetS were low level of high density lipoprotein (HDL) and triglyceride(TG). By usingIDF criteria, female gender was significantly associated with MetS (AOR = 0.2 at 95%CI: 0.1, 0.6 P = 0.00). Where as by NCEP-ATP IIIcriteria, age between 51 and 64 years old (AOR = 2.4 95% CI: 1.0,5.8, P = 0.04), self employment (AOR = 2.7 95% CI:1.1, 6.5, P = 0.03), and completetion of secondary school and above (AOR = 3.2, 95% CI:1.6,6.7, P = 0.001) were predictors for the development of MetS. In the WHO criteria, being single in marital status was significantly associated with MetS (AOR = 17 at 95%CI: 1.8, 166, P = 0.000).

Conclusions: This study demonstrates that Metabolic syndrome is a major health concern for diabetic patients in Ethiopia and they are at increased risk of developing complications such as cardiovascular diseases and premature mortality. The predictors female gender, age between 51 and 64 years old, urban area residence, and being single are modifiable.Thus,health authorities shall provide targeted interventions such as life style modifications to these most at risk sub-populations of diabetic patients.

Citing Articles

Prevalence and determinants of metabolic syndrome among type2 diabetic patients using different diagnosis criteria in ethiopia: systematic review and meta-analysis.

Mekonnen C, Abate H, Azagew A, Zegeye A BMC Public Health. 2025; 25(1):121.

PMID: 39794754 PMC: 11721325. DOI: 10.1186/s12889-025-21315-4.


Metabolic syndrome among type 2 Diabetes Mellitus patients in Ethiopia: a systematic review and meta-analysis.

Charkos T, Lemi H, Arero G, Getnet M Front Clin Diabetes Healthc. 2024; 5:1437288.

PMID: 39669751 PMC: 11634832. DOI: 10.3389/fcdhc.2024.1437288.


Diabetic dyslipidemia and its predictors among people with diabetes in Ethiopia: systematic review and meta-analysis.

Azagew A, Abate H, Mekonnen C, Mekonnen H, Tezera Z, Jember G Syst Rev. 2024; 13(1):190.

PMID: 39033198 PMC: 11264949. DOI: 10.1186/s13643-024-02593-2.


Prevalence of dyslipidemia among persons with type 2 diabetes in Africa: a systematic review and meta-analysis.

Ekpor E, Addo-Mensah D, Akyirem S Ann Med Surg (Lond). 2024; 86(6):3468-3477.

PMID: 38846843 PMC: 11152840. DOI: 10.1097/MS9.0000000000002122.


Exploring the Prevalence and Components of Metabolic Syndrome in Sub-Saharan African Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.

Musilanga N, Nasib H, Jackson G, Shayo F, Nhanga C, Girukwigomba S J Obes. 2024; 2024:1240457.

PMID: 38410415 PMC: 10896656. DOI: 10.1155/2024/1240457.


References
1.
Matheus A, Tannus L, Cobas R, Palma C, Negrato C, Gomes M . Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013; 2013:653789. PMC: 3603160. DOI: 10.1155/2013/653789. View

2.
Alberti K, Zimmet P . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7):539-53. DOI: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. View

3.
Boudreau D, Malone D, Raebel M, Fishman P, Nichols G, Feldstein A . Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord. 2009; 7(4):305-14. DOI: 10.1089/met.2008.0070. View

4.
Woyesa S, Hirigo A, Wube T . Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr Disord. 2017; 17(1):76. PMC: 5728062. DOI: 10.1186/s12902-017-0226-y. View

5.
Devers M, Campbell S, Simmons D . Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease. BMJ Open Diabetes Res Care. 2016; 4(1):e000195. PMC: 4853802. DOI: 10.1136/bmjdrc-2016-000195. View